
Intends to provide fill-and-finish services for up to 200 million doses

Intends to provide fill-and-finish services for up to 200 million doses

The CRO establishes new legal entity and regional office in Tokyo

Pharmaceutical Cargo Security Coalition (PCSC) adds to its advisory services

Pfizer is working with local law enforcement to counter the threat

Digital supply network creation tool can enable industries to work together, company says

European Medicines Agency confirms that the benefits exceed the risks

Companies will work together on delivering improved patient access and clinical trial diversity

Survey-based data uncovers ways to streamline the trial activation process and improve operations at the site level

Company offers a plug-and-play bundle of tags, readers and data collection

Jody Hatcher, an experienced GPO executive, will be CEO

Deal gives leader in lab instruments and tests a big push into pharma service and clinical research space

Global service arrangement allows for transport that meets various temperature demands

Partnership focused around providing real-world patient insight through advanced data and technologies

Following strong data backing of the combined drug therapy, Lilly revises its supply deal with the US government

Amended emergency use authorization would include 12-15 year olds

Unnamed EU official says up to 1.8 billion doses could be delivered in 2022 and 2023

Most recent figures show air freight is outperforming last year’s pre-Covid marks

Acquisition adds AI, machine-learning capabilities to the payment experience

New benchmark is expected to be met by end of 2021, BioNTech says

Company markets unique approach to managing pharma supply chains

Deal allows for more transport options, temperature control

FourKites will serve as the central data hub for all Cardinal Health shipments

Makes up to 400 million doses of J&J's Covid vaccine available to the African Union through 2022

Opens up additional European sites for dose manufacturing

Report: HHS stops shipping of the solo therapy due to variant impact